Silver Book Fact

A meta-analysis of clinical trials found that calcium supplements reduced the risk of vertebral fractures by around 23%.

Shea, Beverley, George Wells, Ann Cranney, Nicole Zytaruk, Vivian Robinson, Lauren Griffith, Zulma Ortiz, Joan Peterson, Jonathan Adachi, Peter Tugwell, and Gordon Guyatt. Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis. Endocr Rev. 2002; 23(4): 552-9. http://edrv.endojournals.org/cgi/content/full/23/4/552

Reference

Title
Meta-Analysis of Calcium Supplementation for the Prevention of Postmenopausal Osteoporosis
Publication
Endocr Rev
Publication Date
2002
Authors
Shea, Beverley, George Wells, Ann Cranney, Nicole Zytaruk, Vivian Robinson, Lauren Griffith, Zulma Ortiz, Joan Peterson, Jonathan Adachi, Peter Tugwell, and Gordon Guyatt
Volume & Issue
Volume 23, Issue 4
Pages
552-9
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Treatment with zoledronic acid over a 3-year period reduced risk of vertebral fracture by around 70% and risk of hip fracture by 41%, and increased bone mineral density (BMD) by…  
  • Teriparatide, or human recombinant PTH, has been shown to decrease vertebral fractures by 65% to 69%, and non-vertebral fragility fractures by around 53%.  
  • A meta-analysis of clinical trials found that Vitamin D supplements reduced the risk of vertebral fractures by around 37%.  
  • Risedronate, a bisphosphonate, has been shown to increase vertebral bone mineral density (BMD) by around 5% and hip BMD by 2% to 3% in postmenopausal women with osteoporosis.  
  • A meta-analysis of clinical trials found that calcium supplements reduced the risk of vertebral fractures by around 23%.